Autoantibodies in neuromuscular disorders: a review of their utility in clinical practice

A great proportion of neuromuscular diseases are immune-mediated, included myasthenia gravis, Lambert-Eaton myasthenic syndrome, acute- and chronic-onset autoimmune neuropathies (anti-MAG neuropathy, multifocal motor neuropathy, Guillain-Barré syndromes, chronic inflammatory demyelinating polyradicu...

Celý popis

Uloženo v:
Podrobná bibliografie
Vydáno v:Frontiers in neurology Ročník 15; s. 1495205
Hlavní autoři: Loser, Valentin, Vicino, Alex, Théaudin, Marie
Médium: Journal Article
Jazyk:angličtina
Vydáno: Switzerland Frontiers Media S.A 01.11.2024
Témata:
autoantibodies
clinical practice
detection method
neuromuscular diseases
review
clinical practice
neuromuscular diseases
autoantibodies
detection method
review
ISSN:1664-2295, 1664-2295
On-line přístup:Získat plný text
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo vytvoří štítek k tomuto záznamu!
Abstract A great proportion of neuromuscular diseases are immune-mediated, included myasthenia gravis, Lambert-Eaton myasthenic syndrome, acute- and chronic-onset autoimmune neuropathies (anti-MAG neuropathy, multifocal motor neuropathy, Guillain-Barré syndromes, chronic inflammatory demyelinating polyradiculoneuropathy, CANDA and autoimmune nodopathies), autoimmune neuronopathies, peripheral nerve hyperexcitability syndromes and idiopathic inflammatory myopathies. The detection of autoantibodies against neuromuscular structures has many diagnostic and therapeutic implications and, over time, allowed a better understanding of the physiopathology of those disorders. In this paper, we will review the main autoantibodies described in neuromuscular diseases and focus on their use in clinical practice.
AbstractList A great proportion of neuromuscular diseases are immune-mediated, included myasthenia gravis, Lambert-Eaton myasthenic syndrome, acute- and chronic-onset autoimmune neuropathies (anti-MAG neuropathy, multifocal motor neuropathy, Guillain-Barré syndromes, chronic inflammatory demyelinating polyradiculoneuropathy, CANDA and autoimmune nodopathies), autoimmune neuronopathies, peripheral nerve hyperexcitability syndromes and idiopathic inflammatory myopathies. The detection of autoantibodies against neuromuscular structures has many diagnostic and therapeutic implications and, over time, allowed a better understanding of the physiopathology of those disorders. In this paper, we will review the main autoantibodies described in neuromuscular diseases and focus on their use in clinical practice.A great proportion of neuromuscular diseases are immune-mediated, included myasthenia gravis, Lambert-Eaton myasthenic syndrome, acute- and chronic-onset autoimmune neuropathies (anti-MAG neuropathy, multifocal motor neuropathy, Guillain-Barré syndromes, chronic inflammatory demyelinating polyradiculoneuropathy, CANDA and autoimmune nodopathies), autoimmune neuronopathies, peripheral nerve hyperexcitability syndromes and idiopathic inflammatory myopathies. The detection of autoantibodies against neuromuscular structures has many diagnostic and therapeutic implications and, over time, allowed a better understanding of the physiopathology of those disorders. In this paper, we will review the main autoantibodies described in neuromuscular diseases and focus on their use in clinical practice.
A great proportion of neuromuscular diseases are immune-mediated, included myasthenia gravis, Lambert-Eaton myasthenic syndrome, acute- and chronic-onset autoimmune neuropathies (anti-MAG neuropathy, multifocal motor neuropathy, Guillain-Barré syndromes, chronic inflammatory demyelinating polyradiculoneuropathy, CANDA and autoimmune nodopathies), autoimmune neuronopathies, peripheral nerve hyperexcitability syndromes and idiopathic inflammatory myopathies. The detection of autoantibodies against neuromuscular structures has many diagnostic and therapeutic implications and, over time, allowed a better understanding of the physiopathology of those disorders. In this paper, we will review the main autoantibodies described in neuromuscular diseases and focus on their use in clinical practice.
Author Loser, Valentin
Théaudin, Marie
Vicino, Alex
Author_xml – sequence: 1
  givenname: Valentin
  surname: Loser
  fullname: Loser, Valentin
– sequence: 2
  givenname: Alex
  surname: Vicino
  fullname: Vicino, Alex
– sequence: 3
  givenname: Marie
  surname: Théaudin
  fullname: Théaudin, Marie
BackLink https://www.ncbi.nlm.nih.gov/pubmed/39555481$$D View this record in MEDLINE/PubMed
BookMark eNp9kT1vFDEQhi0URELIH6BAW9Lc4c9dmy6KyIcUiYYUqaxZewyOfOvD9oLy77OXuyBEwRSekfW-z1h-35KjKU9IyHtG10Jo8ylMOJc1p1yumTSKU_WKnLC-lyvOjTr6az4mZ7U-0KWEMaIXb8ixMEopqdkJuT-fW4apxTH7iLWLU7cD581c3ZygdD7WXDyW-rmDruCviL-7HLr2A2Pp5hZTbI87l0txig5Sty3gWnT4jrwOkCqeHfopubv88u3ienX79erm4vx25SQTbeUxUOm00qMOfTBqGHCgI2jKAhN08Ho5kY6KMjGARCbDODoDvVDCO6FRnJKbPddneLDbEjdQHm2GaJ8vcvluoSwPSmjd4NBz1WvUKAG5piFo6TnT6BBALqyPe9a25J8z1mY3sTpMCSbMc7WCcdNrzXq2SD8cpPO4Qf9n8cvXLgK9F7iSay0YrIsNWsxTKxCTZdTugrTPQdpdkPYQ5GLl_1hf6P8xPQGOV6Lq
CitedBy_id crossref_primary_10_3389_fneur_2025_1617545
Cites_doi 10.5152/eurasianjmed.2017.17009
10.1093/brain/awh605
10.1212/NXI.0000000000001109
10.1212/WNL.0b013e3182407982
10.1016/S0022-510X(96)05303-8
10.1002/mus.20854
10.1186/s12883-016-0657-5
10.1016/S1474-4422(18)30254-0
10.1007/s00415-019-09367-0
10.1212/CON.0000000000001461
10.1212/WNL.0b013e3181b59a80
10.1016/0092-8674(91)90184-Z
10.1016/j.mayocp.2018.05.033
10.1093/brain/awn092
10.1007/s00415-023-11798-9
10.1007/s00415-022-11262-0
10.1002/mus.27954
10.1111/ene.16073
10.1186/s12974-021-02301-0
10.1016/j.nmd.2016.04.004
10.1002/mus.26392
10.1016/0090-1229(77)90027-7
10.1016/j.jneuroim.2008.03.017
10.1016/j.jaut.2013.12.004
10.1111/ene.12270
10.1016/j.autneu.2008.11.013
10.1002/ana.26050
10.1212/WNL.0000000000008472
10.1056/NEJM199506013322203
10.1093/brain/awf006
10.1136/jnnp-2017-315720
10.1136/jnnp.45.1.83
10.1212/NXI.0000000000200068
10.3389/fimmu.2023.1212757
10.1097/WCO.0000000000000475
10.1038/90050
10.1016/j.nmd.2006.05.006
10.3389/fneur.2021.665136
10.1002/ana.410370218
10.1136/jnnp-2019-321849
10.1002/acn3.26
10.1002/mus.27745
10.1016/0022-510X(85)90144-3
10.1001/jamaneurol.2015.0203
10.1159/000116045
10.1111/ene.13508
10.1016/j.cccn.2004.05.008
10.1016/S1474-4422(23)00077-7
10.1016/j.nmd.2016.10.008
10.1016/j.autrev.2021.102988
10.1093/brain/124.10.1968
10.1212/NXI.0000000000001129
10.1136/jnnp-2011-300309
10.1111/j.1529-8027.2012.00407.x
10.1212/NXI.0000000000000962
10.1136/jnnp-2014-309730
10.1001/archneur.1980.00500590061010
10.1016/j.autrev.2009.01.015
10.1016/j.nbd.2021.105537
10.1016/S0165-5728(00)00431-8
10.1136/jnnp-2013-305397
10.1200/JCO.2010.32.0440
10.1093/brain/awac090
10.1212/WNL.59.5.764
10.1111/ene.14180
10.1212/WNL.0000000000004341
10.1212/NXI.0000000000001162
10.1007/s00415-018-8853-4
10.1002/mus.26748
10.1097/NEN.0b013e31824d1df2
10.1002/ana.23794
10.1093/rheumatology/keaa021
10.1212/01.WNL.0000081229.88862.C6
10.1016/S0022-510X(99)00174-4
10.1200/JCO.2008.20.6169
10.1371/journal.pone.0125339
10.1002/ana.25279
10.1212/NXI.0000000000001028
10.1002/mus.26404
10.1212/01.wnl.0000281663.81079.24
10.1002/jca.21944
10.2478/rir-2022-0001
10.1016/j.neurol.2023.02.064
10.1177/1756285617746640
10.1007/s00415-018-9143-x
10.1212/01.WNL.0000129274.12702.92
10.1007/s004150050604
10.1002/ana.23840
10.1111/ene.15238
10.1016/j.jneuroim.2022.577850
10.1016/j.jns.2013.11.025
10.1097/CND.0000000000000355
10.7554/eLife.23043
10.1136/annrheumdis-2017-211468
10.1016/j.expneurol.2016.10.006
10.1093/brain/aww189
10.1212/WNL.47.4.951
10.1002/mus.26156
10.1111/j.1471-4159.2006.04319.x
10.1056/NEJMoa1602489
10.1038/nrneurol.2011.175
10.1002/mus.23256
10.1212/WNL.57.4.736
10.1212/01.wnl.0000903272.62514.70
10.1016/j.jneuroim.2020.577288
10.1097/WCO.0000000000001107
10.1182/blood.2020007092
10.1212/NXI.0000000000000819
10.1016/j.nmd.2024.03.001
10.1002/mus.22006
10.1212/WNL.0000000000004803
10.1038/s41584-020-00515-9
10.1046/j.1468-1331.1999.610071.x
10.1002/acn3.51775
10.1007/s00415-008-0775-0
10.1212/NXI.0000000000001032
10.1016/S1474-4422(23)00080-7
10.1212/NXI.0000000000200105
10.1111/nyas.13518
10.1212/NXI.0000000000000603
10.1016/j.cca.2015.07.030
10.1002/mus.20307
10.1111/j.1529-8027.2010.00290.x
10.1111/nyas.13592
10.1093/brain/awae302
10.1212/WNL.0000000000209725
10.1002/ana.410400414
10.1111/jns.12569
10.1371/journal.pone.0284409
10.1093/rheumatology/keq281
10.1002/mus.23944
10.1001/archneur.58.6.885
10.1016/S1474-4422(14)70051-1
10.1212/NXI.0000000000200081
10.1016/j.neuroscience.2005.04.066
10.1212/WNL.56.9.1227
10.1212/NXI.0000000000000357
10.1016/j.autneu.2008.10.022
10.1111/nyas.13522
10.4061/2011/474512
10.1007/s004010050847
10.1212/WNL.31.2.220
10.1097/WCO.0000000000000963
10.1111/joim.12451
10.1002/ana.410240113
10.1002/mus.10301
10.1007/s10096-013-2040-4
10.1093/brain/122.3.449
10.1001/archneur.57.11.1596
10.1001/jamaneurol.2018.2598
10.1002/ana.410310619
10.1212/WNL.0000000000011124
10.1016/0022-510X(83)90096-5
10.1093/brain/aws025
10.1056/NEJM200009213431204
10.1016/S1474-4422(17)30329-0
10.1002/acr.22600
10.1016/S1474-4422(21)00159-9
10.1371/journal.pone.0114060
10.1016/S1474-4422(21)00297-0
10.1212/NXI.0000000000000771
10.1001/archneurol.2009.341
10.1002/ana.410440620
10.1136/jnnp.11.2.73
10.1212/WNL.33.10.1276
10.1016/j.lanwpc.2023.100846
10.1002/mus.26447
10.3389/fimmu.2019.00769
10.1001/jamaneurol.2022.1357
10.1002/1531-8249(199902)45:2<168:AID-ANA6>3.0.CO;2-6
10.1111/j.1529-8027.2012.00372.x
10.1073/pnas.97.8.4198
10.1111/ene.13922
10.1097/00000658-198208000-00001
10.1007/s10072-019-03746-1
10.1136/jnnp.70.1.50
10.1016/j.neuron.2018.01.033
10.1007/s00415-023-11699-x
10.1212/01.wnl.0000228225.23349.5d
10.1097/CND.0000000000000241
10.1002/acn3.314
10.1002/mus.24192
10.1093/brain/awx124
10.5402/2012/506160
10.1093/brain/awab014
10.1007/s11926-018-0732-6
10.1111/ene.14959
10.1212/WNL.0000000000000205
10.1002/acr.22163
10.1002/mus.25027
10.1093/brain/awp136
10.1212/01.WNL.0000144340.03364.BF
10.1016/j.nmd.2022.05.011
10.1212/NXI.0000000000001014
10.1097/WCO.0000000000001104
10.1136/jnnp.72.6.767
10.1136/jnnp-2021-326343
10.1002/mus.24559
10.3389/fimmu.2019.00745
10.1136/jnnp-2019-321532
10.1111/ene.15523
10.1111/j.1749-6632.2012.06772.x
10.1002/ana.26268
10.1038/s41572-021-00321-x
10.1007/s00415-022-11458-4
ContentType Journal Article
Copyright Copyright © 2024 Loser, Vicino and Théaudin.
Copyright_xml – notice: Copyright © 2024 Loser, Vicino and Théaudin.
DBID AAYXX
CITATION
NPM
7X8
DOA
DOI 10.3389/fneur.2024.1495205
DatabaseName CrossRef
PubMed
MEDLINE - Academic
DOAJ Directory of Open Access Journals
DatabaseTitle CrossRef
PubMed
MEDLINE - Academic
DatabaseTitleList MEDLINE - Academic
PubMed
CrossRef
Database_xml – sequence: 1
  dbid: DOA
  name: DOAJ Directory of Open Access Journals
  url: https://www.doaj.org/
  sourceTypes: Open Website
– sequence: 2
  dbid: NPM
  name: PubMed
  url: http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
– sequence: 3
  dbid: 7X8
  name: MEDLINE - Academic
  url: https://search.proquest.com/medline
  sourceTypes: Aggregation Database
DeliveryMethod fulltext_linktorsrc
Discipline Medicine
EISSN 1664-2295
ExternalDocumentID oai_doaj_org_article_c7ced2568e8e4ae280ff84d218eceaa4
39555481
10_3389_fneur_2024_1495205
Genre Journal Article
Review
GroupedDBID 53G
5VS
9T4
AAFWJ
AAKDD
AAYXX
ACGFO
ACGFS
ADBBV
ADRAZ
AENEX
AFPKN
ALMA_UNASSIGNED_HOLDINGS
AOIJS
BAWUL
BCNDV
CITATION
DIK
E3Z
EMOBN
F5P
GROUPED_DOAJ
GX1
HYE
KQ8
M48
M~E
O5R
O5S
OK1
P2P
PGMZT
RNS
RPM
ACXDI
IPNFZ
NPM
RIG
7X8
ID FETCH-LOGICAL-c413t-def04c858b8f6f9577e70ba801f1307d8130e0b50137a4e14fbbc9a6353dc38e3
IEDL.DBID DOA
ISICitedReferencesCount 1
ISICitedReferencesURI http://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=Summon&SrcAuth=ProQuest&DestLinkType=CitingArticles&DestApp=WOS_CPL&KeyUT=001356556900001&url=https%3A%2F%2Fcvtisr.summon.serialssolutions.com%2F%23%21%2Fsearch%3Fho%3Df%26include.ft.matches%3Dt%26l%3Dnull%26q%3D
ISSN 1664-2295
IngestDate Fri Oct 03 12:51:24 EDT 2025
Wed Oct 01 13:37:14 EDT 2025
Thu Apr 03 06:57:40 EDT 2025
Sat Nov 29 01:41:16 EST 2025
Tue Nov 18 21:25:54 EST 2025
IsDoiOpenAccess true
IsOpenAccess true
IsPeerReviewed true
IsScholarly true
Keywords clinical practice
neuromuscular diseases
autoantibodies
detection method
review
Language English
License Copyright © 2024 Loser, Vicino and Théaudin.
LinkModel DirectLink
MergedId FETCHMERGED-LOGICAL-c413t-def04c858b8f6f9577e70ba801f1307d8130e0b50137a4e14fbbc9a6353dc38e3
Notes ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
ObjectType-Review-3
content type line 23
OpenAccessLink https://doaj.org/article/c7ced2568e8e4ae280ff84d218eceaa4
PMID 39555481
PQID 3129688161
PQPubID 23479
ParticipantIDs doaj_primary_oai_doaj_org_article_c7ced2568e8e4ae280ff84d218eceaa4
proquest_miscellaneous_3129688161
pubmed_primary_39555481
crossref_citationtrail_10_3389_fneur_2024_1495205
crossref_primary_10_3389_fneur_2024_1495205
PublicationCentury 2000
PublicationDate 2024-11-01
PublicationDateYYYYMMDD 2024-11-01
PublicationDate_xml – month: 11
  year: 2024
  text: 2024-11-01
  day: 01
PublicationDecade 2020
PublicationPlace Switzerland
PublicationPlace_xml – name: Switzerland
PublicationTitle Frontiers in neurology
PublicationTitleAlternate Front Neurol
PublicationYear 2024
Publisher Frontiers Media S.A
Publisher_xml – name: Frontiers Media S.A
References Benatar (ref55) 2001; 113
Graus (ref56) 2002; 59
Taieb (ref126) 2019; 59
Lilleker (ref196) 2024; 37
Ruiz-García (ref64) 2019; 10
Camdessanché (ref110) 2012; 71
Bartoccioni (ref35) 2006; 67
Titulaer (ref52) 2011; 29
Vallat (ref122) 2017; 27
Oosterhuis (ref9) 1985; 69
Denny-Brown (ref150) 1948; 11
Marcuse (ref14) 2022; 29
Jacobs (ref83) 1995; 37
do (ref147) 2021; 8
van den Bergh (ref94) 2021; 28
Zisimopoulou (ref43) 2014; 52
Devic (ref26) 2014; 21
Pascual-Goñi (ref128) 2021; 144
Garcia-Santibanez (ref98) 2018; 265
Graus (ref112) 2021; 8
Vincent (ref28) 2018; 1413
Ohta (ref36) 2004; 62
Mori (ref142) 2005; 128
Pestronk (ref101) 1988; 24
Querol (ref120) 2014; 82
Roses (ref11) 1981; 31
(ref116) 2010; 15
Dubey (ref186) 2022; 79
Dubey (ref108) 2018; 90
Ho (ref67) 1999; 45
Liberatore (ref90) 2020; 345
Olanow (ref12) 1982; 196
Peillet (ref99) 2022; 29
Gastaldi (ref181) 2019; 26
De Wel (ref177) 2021; 34
Benatar (ref5) 2006; 16
Zautner (ref78) 2014; 33
Sabater (ref61) 2008; 70
Vlam (ref103) 2011; 8
Werner (ref158) 2021; 8
Pestronk (ref167) 2012; 45
Li (ref135) 2015; 52
Sista (ref159) 2022; 269
Taylor (ref104) 1996; 47
Giometto (ref151) 2010; 67
Howard (ref21) 2023; 22
Wolfe (ref17) 2016; 375
Güre (ref59) 2000; 97
Halilu (ref202) 2022; 3
Kwon (ref33) 2023; 270
Antoine (ref111) 2017; 30
Tholance (ref144) 2020; 91
Sanders (ref13) 2014; 49
Vakrakou (ref37) 2023; 14
Molinuevo (ref155) 1998; 44
Lundberg (ref191) 2017; 76
Roth (ref100) 2004; 25
Howard (ref2) 2018; 1412
Querol (ref118) 2013; 73
Cutsforth-Gregory (ref137) 2018; 93
Evoli (ref31) 2018; 1412
Beecher (ref40) 2018; 58
Olsen (ref171) 2022; 37
Quarles (ref87) 2007; 100
le Cann (ref95) 2020; 136
Sandroni (ref138) 2009; 146
Huijbers (ref45) 2016; 26
Dalakas (ref88) 2018; 11
Rojas-García (ref84) 2012; 17
Delmont (ref121) 2017; 140
Vernino (ref133) 2000; 343
Lipka (ref62) 2012; 1275
Martín-Aguilar (ref117) 2022; 35
Sheikh (ref79) 1999; 122
Lladó (ref156) 2004; 63
Dubey (ref163) 2021; 89
Guptill (ref29) 2011; 44
Chan (ref51) 2007; 36
Hehir (ref38) 2017; 89
Clifford (ref42) 2019; 59
Willison (ref97) 2001; 124
Gibbons (ref136) 2009; 146
Tansley (ref201) 2020; 59
Svahn (ref187) 2023; 10
Evoli (ref50) 2019; 40
Betteridge (ref192) 2016; 280
Chiba (ref80) 1992; 31
Stengel (ref131) 2019; 6
Selva-O'Callaghan (ref188) 2018; 17
Bril (ref23) 2023; 22
Mariampillai (ref190) 2018; 75
Uncini (ref130) 2023
Dubey (ref107) 2024; 30
Levine (ref168) 2020; 61
Kollewe (ref105) 2015; 10
Collet (ref114) 2023; 179
Martín-Aguilar (ref123) 2022; 9
Vincent (ref7) 1983; 33
Miyazaki (ref74) 2001; 56
Vogrig (ref161) 2019; 266
Masi (ref27) 2022; 367
Kolter (ref65) 2012; 2012
Tschernatsch (ref63) 2009; 8
Liu (ref129) 2023; 10
Ito (ref82) 2008; 255
Rodríguez Cruz (ref25) 2015; 72
Lindstrom (ref3) 1977; 7
Fels (ref182) 2021; 160
Lamb (ref184) 2005; 31
Moritz (ref148) 2023; 10
de Greef (ref165) 2018; 25
Binks (ref179) 2018; 89
Sekiguchi (ref76) 2012; 83
Dalakas (ref106) 1980; 37
Kuijf (ref89) 2009; 73
Diard-Detoeuf (ref162) 2014; 337
Leite (ref24) 2008; 131
Romi (ref49) 2000; 57
Hänggi (ref91) 2021; 9
Chan (ref176) 2022; 91
Betz (ref185) 2001; 28
Huda (ref34) 2017; 4
Oosterhuis (ref8) 1983; 58
Majed (ref58) 2022; 99
Fehmi (ref86) 2021; 92
Allenbach (ref194) 2020; 16
Sabater (ref157) 2014; 13
Díaz-Manera (ref39) 2012; 78
Klooster (ref30) 2012; 135
Fujii (ref174) 2020; 7
Li (ref6) 2023; 38
Stino (ref92) 2023; 68
Yamamoto (ref47) 2001; 58
Kaida (ref70) 2003; 61
Dawes (ref180) 2018; 97
Zeidman (ref170) 2021; 22
Amlani (ref199) 2019; 10
Karagiorgou (ref140) 2022; 9
Lundberg (ref189) 2021; 7
Fujii (ref173) 2018; 84
Sagar (ref149) 1982; 45
Willison (ref113) 1999; 6
Dubey (ref125) 2020; 7
Szabo (ref153) 1991; 67
Kira (ref124) 2021; 12
Pascual-Goñi (ref205) 2024; 103
Grüter (ref160) 2023; 146
Kusunoki (ref73) 2001; 57
Dubey (ref109) 2019; 93
Tzartos (ref44) 2014; 1
Zhang (ref132) 2023; 10
Antoine (ref143) 2015; 86
Heldal (ref10) 2014; 9
O'Hanlon (ref66) 1998; 95
Punga (ref48) 2022; 21
Farah (ref183) 2024
Gibbons (ref172) 2023; 67
Aydin (ref16) 2017; 49
Fujii (ref175) 2021; 8
Vernino (ref134) 2008; 197
Wakerley (ref85) 2014; 85
Terkelsen (ref164) 2017; 16
Chompoopong (ref169) 2023; 270
Lee (ref200) 2023; 18
Comperat (ref178) 2022; 35
Koga (ref68) 2002; 72
Delmont (ref93) 2019; 266
Matthews (ref32) 2004; 348
Appeltshauser (ref127) 2017; 287
Lleixà (ref71) 2021; 18
Yako (ref72) 1999; 168
Sawaya (ref69) 2019; 21
Doppler (ref119) 2016; 139
van Doorn (ref115) 2023; 30
Titulaer (ref60) 2009; 27
Urriola (ref139) 2022; 21
Narayanaswami (ref18) 2021; 96
Hafer-Macko (ref77) 1996; 40
Kovvuru (ref145) 2020; 27
Lloyd (ref198) 2016; 68
Odaka (ref81) 2001; 70
Schwenkenbecher (ref154) 2016; 16
Howard (ref22) 2021; 20
Ghirardello (ref203) 2010; 49
Anderson (ref41) 2016; 3
Muppidi (ref19) 2019; 60
Zalewski (ref57) 2016; 54
Devaux (ref75) 2012; 17
Noridomi (ref1) 2017; 6
Jungnickel (ref146) 2005; 134
Romi (ref46) 2000; 247
Pestronk (ref166) 2003; 27
Pinal-Fernandez (ref193) 2018; 20
Camdessanche (ref141) 2009; 132
Camdessanché (ref152) 2002; 125
Meisel (ref20) 2023; 270
Yuki (ref96) 2014; 49
Motomura (ref54) 1997; 147
Benjamin Larman (ref197) 2013; 73
Kaji (ref195) 2014; 66
Oger (ref4) 2015; 449
Yeh (ref102) 2020; 91
Damoiseaux (ref204) 2022; 32
Lennon (ref53) 1995; 332
Romi (ref15) 2011; 2011
References_xml – volume: 49
  start-page: 48
  year: 2017
  ident: ref16
  article-title: Thymectomy in myasthenia gravis
  publication-title: Eurasian J Med
  doi: 10.5152/eurasianjmed.2017.17009
– volume: 128
  start-page: 2518
  year: 2005
  ident: ref142
  article-title: The wide spectrum of clinical manifestations in Sjögren’s syndrome-associated neuropathy
  publication-title: Brain
  doi: 10.1093/brain/awh605
– volume: 9
  start-page: e1109
  year: 2021
  ident: ref91
  article-title: Decrease in serum anti-MAG autoantibodies is associated with therapy response in patients with anti-MAG neuropathy: retrospective study
  publication-title: Neurol Neuroimmunol Neuroinflamm
  doi: 10.1212/NXI.0000000000001109
– volume: 78
  start-page: 189
  year: 2012
  ident: ref39
  article-title: Long-lasting treatment effect of rituximab in MuSK myasthenia
  publication-title: Neurology
  doi: 10.1212/WNL.0b013e3182407982
– volume: 147
  start-page: 35
  year: 1997
  ident: ref54
  article-title: Incidence of serum anti-P/O-type and anti-N-type calcium channel autoantibodies in the Lambert-Eaton myasthenic syndrome
  publication-title: J Neurol Sci
  doi: 10.1016/S0022-510X(96)05303-8
– volume: 36
  start-page: 651
  year: 2007
  ident: ref51
  article-title: Frequency of seronegativity in adult-acquired generalized myasthenia gravis
  publication-title: Muscle Nerve
  doi: 10.1002/mus.20854
– volume: 16
  start-page: 136
  year: 2016
  ident: ref154
  article-title: Intrathecal synthesis of anti-Hu antibodies distinguishes patients with paraneoplastic peripheral neuropathy and encephalitis
  publication-title: BMC Neurol
  doi: 10.1186/s12883-016-0657-5
– volume: 17
  start-page: 816
  year: 2018
  ident: ref188
  article-title: Classification and management of adult inflammatory myopathies
  publication-title: Lancet Neurol
  doi: 10.1016/S1474-4422(18)30254-0
– volume: 266
  start-page: 1973
  year: 2019
  ident: ref93
  article-title: Relevance of anti-HNK1 antibodies in the management of anti-MAG neuropathies
  publication-title: J Neurol
  doi: 10.1007/s00415-019-09367-0
– volume: 30
  start-page: 1136
  year: 2024
  ident: ref107
  article-title: Autoimmune neuromuscular disorders associated with neural antibodies
  publication-title: Continuum
  doi: 10.1212/CON.0000000000001461
– volume: 73
  start-page: 688
  year: 2009
  ident: ref89
  article-title: Detection of anti-MAG antibodies in polyneuropathy associated with IgM monoclonal gammopathy
  publication-title: Neurology
  doi: 10.1212/WNL.0b013e3181b59a80
– volume: 67
  start-page: 325
  year: 1991
  ident: ref153
  article-title: HuD, a paraneoplastic encephalomyelitis antigen, contains RNA-binding domains and is homologous to Elav and sex-lethal
  publication-title: Cell
  doi: 10.1016/0092-8674(91)90184-Z
– volume: 93
  start-page: 1440
  year: 2018
  ident: ref137
  article-title: Ganglionic antibody level as a predictor of severity of autonomic failure
  publication-title: Mayo Clin Proc
  doi: 10.1016/j.mayocp.2018.05.033
– volume: 131
  start-page: 1940
  year: 2008
  ident: ref24
  article-title: IgG1 antibodies to acetylcholine receptors in 'seronegative' myasthenia gravis
  publication-title: Brain
  doi: 10.1093/brain/awn092
– volume: 270
  start-page: 4523
  year: 2023
  ident: ref169
  article-title: TS-HDS autoantibody: clinical characterization and utility from real-world tertiary care center experience
  publication-title: J Neurol
  doi: 10.1007/s00415-023-11798-9
– volume: 269
  start-page: 6139
  year: 2022
  ident: ref159
  article-title: Motor-neuron-disease-like phenotype associated with IgLON5 disease
  publication-title: J Neurol
  doi: 10.1007/s00415-022-11262-0
– volume: 68
  start-page: 823
  year: 2023
  ident: ref92
  article-title: Anti-myelin-associated glycoprotein neuropathy: where do we stand?
  publication-title: Muscle Nerve
  doi: 10.1002/mus.27954
– volume: 30
  start-page: 3646
  year: 2023
  ident: ref115
  article-title: European academy of neurology/peripheral nerve society guideline on diagnosis and treatment of Guillain-Barré syndrome
  publication-title: Eur J Neurol
  doi: 10.1111/ene.16073
– volume: 18
  start-page: 2301
  year: 2021
  ident: ref71
  article-title: Autoantibody screening in Guillain-Barré syndrome
  publication-title: J Neuroinflammation
  doi: 10.1186/s12974-021-02301-0
– volume: 26
  start-page: 350
  year: 2016
  ident: ref45
  article-title: Myasthenia gravis with muscle specific kinase antibodies mimicking amyotrophic lateral sclerosis
  publication-title: Neuromuscul Disord
  doi: 10.1016/j.nmd.2016.04.004
– volume: 59
  start-page: E19621
  year: 2019
  ident: ref126
  article-title: “Neuro‐renal syndrome” related to anti‐contactin‐1 antibodies
  publication-title: Muscle Nerve
  doi: 10.1002/mus.26392
– volume: 7
  start-page: 36
  year: 1977
  ident: ref3
  article-title: An assay for antibodies to human acetylcholine receptor in serum from patients with myasthenia gravis
  publication-title: Clin Immunol Immunopathol
  doi: 10.1016/0090-1229(77)90027-7
– volume: 197
  start-page: 63
  year: 2008
  ident: ref134
  article-title: Characterization of ganglionic acetylcholine receptor autoantibodies
  publication-title: J Neuroimmunol
  doi: 10.1016/j.jneuroim.2008.03.017
– volume: 52
  start-page: 139
  year: 2014
  ident: ref43
  article-title: A comprehensive analysis of the epidemiology and clinical characteristics of anti-LRP4 in myasthenia gravis
  publication-title: J Autoimmun
  doi: 10.1016/j.jaut.2013.12.004
– volume: 21
  start-page: 130
  year: 2014
  ident: ref26
  article-title: Antibodies to clustered acetylcholine receptor: expanding the phenotype
  publication-title: Eur J Neurol
  doi: 10.1111/ene.12270
– volume: 146
  start-page: 8
  year: 2009
  ident: ref136
  article-title: Antibody titers predict clinical features of autoimmune autonomic ganglionopathy
  publication-title: Auton Neurosci
  doi: 10.1016/j.autneu.2008.11.013
– volume: 89
  start-page: 1001
  year: 2021
  ident: ref163
  article-title: Leucine zipper 4 autoantibody: A novel germ cell tumor and paraneoplastic biomarker
  publication-title: Ann Neurol
  doi: 10.1002/ana.26050
– volume: 93
  start-page: e1873
  year: 2019
  ident: ref109
  article-title: Amphiphysin-IgG autoimmune neuropathy: a recognizable clinicopathologic syndrome
  publication-title: Neurology
  doi: 10.1212/WNL.0000000000008472
– volume: 332
  start-page: 1467
  year: 1995
  ident: ref53
  article-title: Calcium-channel antibodies in the Lambert-Eaton syndrome and other paraneoplastic syndromes
  publication-title: N Engl J Med
  doi: 10.1056/NEJM199506013322203
– volume: 125
  start-page: 166
  year: 2002
  ident: ref152
  article-title: Paraneoplastic peripheral neuropathy associated with anti‐Hu antibodies
  publication-title: Brain
  doi: 10.1093/brain/awf006
– volume: 89
  start-page: 526
  year: 2018
  ident: ref179
  article-title: LGI1, CASPR2 and related antibodies: a molecular evolution of the phenotypes
  publication-title: J Neurol Neurosurg Psychiatry
  doi: 10.1136/jnnp-2017-315720
– volume: 45
  start-page: 83
  year: 1982
  ident: ref149
  article-title: Subacute sensory neuropathy with remission: an association with lymphoma
  publication-title: J Neurol Neurosurg Psychiatry
  doi: 10.1136/jnnp.45.1.83
– volume: 10
  start-page: e200068
  year: 2023
  ident: ref187
  article-title: Immune-mediated rippling muscle disease associated with thymoma and anti-MURC/ cavin-4 autoantibodies
  publication-title: Neurol Neuroimmunol Neuroinflamm
  doi: 10.1212/NXI.0000000000200068
– volume: 14
  start-page: 1212757
  year: 2023
  ident: ref37
  article-title: Immunotherapies in MuSK-positive myasthenia gravis; an IgG4 antibody-mediated disease
  publication-title: Front Immunol
  doi: 10.3389/fimmu.2023.1212757
– volume: 30
  start-page: 513
  year: 2017
  ident: ref111
  article-title: Paraneoplastic neuropathies
  publication-title: Curr Opin Neurol
  doi: 10.1097/WCO.0000000000000475
– volume: 28
  start-page: 218
  year: 2001
  ident: ref185
  article-title: Mutations in CAV3 cause mechanical hyperirritability of skeletal muscle in rippling muscle disease
  publication-title: Nat Genet
  doi: 10.1038/90050
– volume: 16
  start-page: 459
  year: 2006
  ident: ref5
  article-title: A systematic review of diagnostic studies in myasthenia gravis
  publication-title: Neuromuscul Disord
  doi: 10.1016/j.nmd.2006.05.006
– volume: 12
  start-page: 665136
  year: 2021
  ident: ref124
  article-title: Anti-Neurofascin 155 antibody-positive chronic inflammatory demyelinating polyneuropathy/combined central and peripheral demyelination: strategies for diagnosis and treatment based on the disease mechanism
  publication-title: Front Neurol
  doi: 10.3389/fneur.2021.665136
– volume: 37
  start-page: 260
  year: 1995
  ident: ref83
  article-title: Serum anti-GQ1b IgG antibodies recognize surface epitopes on Campylobacter jejuni from patients with Miller fisher syndrome
  publication-title: Ann Neurol
  doi: 10.1002/ana.410370218
– volume: 91
  start-page: 49
  year: 2020
  ident: ref144
  article-title: Clinical characterisation of sensory neuropathy with anti-FGFR3 autoantibodies
  publication-title: J Neurol Neurosurg Psychiatry
  doi: 10.1136/jnnp-2019-321849
– volume: 1
  start-page: 80
  year: 2014
  ident: ref44
  article-title: LRP4 antibodies in serum and CSF from amyotrophic lateral sclerosis patients
  publication-title: Ann Clin Transl Neurol
  doi: 10.1002/acn3.26
– volume: 67
  start-page: 363
  year: 2023
  ident: ref172
  article-title: A double-blind placebo-controlled pilot study of immunoglobulin for small fiber neuropathy associated with TS-HDS and FGFR-3 autoantibodies
  publication-title: Muscle Nerve
  doi: 10.1002/mus.27745
– volume: 69
  start-page: 335
  year: 1985
  ident: ref9
  article-title: Anti- acetylcholine receptor antibodies in myasthenia gravis. Part 3. The effect of thymectomy
  publication-title: J Neurol Sci
  doi: 10.1016/0022-510X(85)90144-3
– volume: 72
  start-page: 642
  year: 2015
  ident: ref25
  article-title: Clinical features and diagnostic usefulness of antibodies to clustered acetylcholine receptors in the diagnosis of seronegative myasthenia gravis
  publication-title: JAMA Neurol
  doi: 10.1001/jamaneurol.2015.0203
– volume: 25
  start-page: 416
  year: 2004
  ident: ref100
  article-title: Motor neuropathy with proximal multifocal persistent conduction block, fasciculations and myokymia
  publication-title: Psychiatr Neurol
  doi: 10.1159/000116045
– volume: 25
  start-page: 348
  year: 2018
  ident: ref165
  article-title: Associated conditions in small fiber neuropathy - a large cohort study and review of the literature
  publication-title: Eur J Neurol
  doi: 10.1111/ene.13508
– volume: 348
  start-page: 95
  year: 2004
  ident: ref32
  article-title: Muscle-specific receptor tyrosine kinase autoantibodies-a new immunoprecipitation assay
  publication-title: Clin Chim Acta
  doi: 10.1016/j.cccn.2004.05.008
– volume: 22
  start-page: 383
  year: 2023
  ident: ref23
  article-title: Safety and efficacy of rozanolixizumab in patients with generalised myasthenia gravis (MycarinG): a randomised, double-blind, placebo-controlled, adaptive phase 3 study
  publication-title: Lancet Neurol
  doi: 10.1016/S1474-4422(23)00077-7
– volume: 27
  start-page: 290
  year: 2017
  ident: ref122
  article-title: Paranodal lesions in chronic inflammatory demyelinating polyneuropathy associated with antiNeurofascin 155 antibodies
  publication-title: Neuromuscul Disord
  doi: 10.1016/j.nmd.2016.10.008
– volume: 21
  start-page: 102988
  year: 2022
  ident: ref139
  article-title: Autoimmune autonomic ganglionopathy: ganglionic acetylcholine receptor autoantibodies
  publication-title: Autoimmun Rev
  doi: 10.1016/j.autrev.2021.102988
– volume: 124
  start-page: 1968
  year: 2001
  ident: ref97
  article-title: The clinical and laboratory features of chronic sensory ataxic neuropathy with anti-disialosyl IgM antibodies
  publication-title: Brain
  doi: 10.1093/brain/124.10.1968
– volume: 9
  start-page: e1098
  year: 2022
  ident: ref123
  article-title: Clinical and laboratory features in anti-NF155 autoimmune Nodopathy
  publication-title: Neurol Neuroimmunol Neuroinflamm
  doi: 10.1212/NXI.0000000000001129
– volume: 83
  start-page: 23
  year: 2012
  ident: ref76
  article-title: Antiganglioside antibodies are associated with axonal Guillain–Barré syndrome: A Japanese–Italian collaborative study
  publication-title: J Neurol Neurosurg Psychiatry
  doi: 10.1136/jnnp-2011-300309
– volume: 17
  start-page: 158
  year: 2012
  ident: ref84
  article-title: Clinical and serological features of acute sensory ataxic neuropathy with antiganglioside antibodies
  publication-title: J Peripher Nerv Syst
  doi: 10.1111/j.1529-8027.2012.00407.x
– volume: 8
  start-page: e962
  year: 2021
  ident: ref158
  article-title: Anti-IgLON5 disease: A new bulbar-onset motor neuron mimic syndrome
  publication-title: Neurol Neuroimmunol Neuroinflamm.
  doi: 10.1212/NXI.0000000000000962
– volume: 86
  start-page: 1347
  year: 2015
  ident: ref143
  article-title: Antifibroblast growth factor receptor 3 antibodies identify a subgroup of patients with sensory neuropathy
  publication-title: J Neurol Neurosurg Psychiatry
  doi: 10.1136/jnnp-2014-309730
– volume: 37
  start-page: 637640
  year: 1980
  ident: ref106
  article-title: Immunoglobulin and complement deposits in nerves of patients with chronic relapsing polyneuropathy
  publication-title: Arch Neurol
  doi: 10.1001/archneur.1980.00500590061010
– volume: 8
  start-page: 549
  year: 2009
  ident: ref63
  article-title: SOX-1 autoantibodies in patients with paraneoplastic neurological syndromes
  publication-title: Autoimmun Rev
  doi: 10.1016/j.autrev.2009.01.015
– volume: 160
  start-page: 105537
  year: 2021
  ident: ref182
  article-title: Role of LGI1 protein in synaptic transmission: from physiology to pathology
  publication-title: Neurobiol Dis
  doi: 10.1016/j.nbd.2021.105537
– volume: 113
  start-page: 153
  year: 2001
  ident: ref55
  article-title: Presynaptic neuronal antigens expressed by a small cell lung carcinoma cell line
  publication-title: J Neuroimmunol
  doi: 10.1016/S0165-5728(00)00431-8
– volume: 85
  start-page: 339
  year: 2014
  ident: ref85
  article-title: Pharyngeal-cervical-brachial variant of Guillain-Barre syndrome
  publication-title: J Neurol Neurosurg Psychiatry
  doi: 10.1136/jnnp-2013-305397
– volume: 29
  start-page: 902
  year: 2011
  ident: ref52
  article-title: Clinical Dutch-English Lambert-Eaton Myasthenic syndrome (LEMS) tumor association prediction score accurately predicts small-cell lung cancer in the LEMS
  publication-title: J Clin Oncol
  doi: 10.1200/JCO.2010.32.0440
– volume: 146
  start-page: 600
  year: 2023
  ident: ref160
  article-title: Clinical, serological and genetic predictors of response to immunotherapy in anti-IgLON5 disease
  publication-title: Brain
  doi: 10.1093/brain/awac090
– volume: 59
  start-page: 764
  year: 2002
  ident: ref56
  article-title: P/Q type calcium-channel antibodies in paraneoplastic cerebellar degeneration with lung cancer
  publication-title: Neurology
  doi: 10.1212/WNL.59.5.764
– volume: 27
  start-page: 1310
  year: 2020
  ident: ref145
  article-title: Clinical characteristics of fibroblast growth factor receptor 3 antibody-related polyneuropathy: a retrospective study
  publication-title: Eur J Neurol
  doi: 10.1111/ene.14180
– volume: 89
  start-page: 1069
  year: 2017
  ident: ref38
  article-title: Rituximab as treatment for anti-MuSK myasthenia gravis: multicenter blinded prospective review
  publication-title: Neurology
  doi: 10.1212/WNL.0000000000004341
– volume: 9
  start-page: e1162
  year: 2022
  ident: ref140
  article-title: Novel cell-based assay for Alpha-3 nicotinic receptor antibodies detects antibodies exclusively in autoimmune autonomic Ganglionopathy
  publication-title: Neurol Neuroimmunol Neuroinflamm
  doi: 10.1212/NXI.0000000000001162
– volume: 265
  start-page: 1402
  year: 2018
  ident: ref98
  article-title: CANOMAD and other chronic ataxic neuropathies with disialosyl antibodies (CANDA)
  publication-title: J Neurol
  doi: 10.1007/s00415-018-8853-4
– volume: 61
  start-page: 512
  year: 2020
  ident: ref168
  article-title: Cryptogenic small-fiber neuropathies: serum autoantibody binding to trisulfated heparan disaccharide and fibroblast growth factor receptor-3
  publication-title: Muscle Nerve
  doi: 10.1002/mus.26748
– volume: 71
  start-page: 298
  year: 2012
  ident: ref110
  article-title: The collapsin response mediator protein 5 onconeural protein is expressed in Schwann cells under axonal signals and regulates axon-Schwann cell interactions
  publication-title: J Neuropathol Exp Neurol
  doi: 10.1097/NEN.0b013e31824d1df2
– volume: 73
  start-page: 370
  year: 2013
  ident: ref118
  article-title: Antibodies to contactin-1 in chronic inflammatory demyelinating polyneuropathy
  publication-title: Ann Neurol
  doi: 10.1002/ana.23794
– volume: 59
  start-page: 2109
  year: 2020
  ident: ref201
  article-title: The reliability of immunoassays to detect autoantibodies in patients with myositis is dependent on autoantibody specificity
  publication-title: Rheumatology
  doi: 10.1093/rheumatology/keaa021
– volume: 61
  start-page: 465
  year: 2003
  ident: ref70
  article-title: GalNAc-GD1a in human peripheral nerve
  publication-title: Neurology
  doi: 10.1212/01.WNL.0000081229.88862.C6
– volume: 168
  start-page: 85
  year: 1999
  ident: ref72
  article-title: Serum antibody against a peripheral nerve myelin ganglioside, LM1, in Guillain-Barré syndrome
  publication-title: J Neurol Sci
  doi: 10.1016/S0022-510X(99)00174-4
– volume: 27
  start-page: 4260
  year: 2009
  ident: ref60
  article-title: SOX antibodies in small-cell lung cancer and Lambert-Eaton myasthenic syndrome: frequency and relation with survival
  publication-title: J Clin Oncol
  doi: 10.1200/JCO.2008.20.6169
– volume: 10
  start-page: e0125339
  year: 2015
  ident: ref105
  article-title: Anti-ganglioside antibodies in amyotrophic lateral sclerosis revisited
  publication-title: PLoS One
  doi: 10.1371/journal.pone.0125339
– volume: 84
  start-page: 208
  year: 2018
  ident: ref173
  article-title: A novel autoantibody against Plexin D1 in patients with neuropathic pain
  publication-title: Ann Neurol
  doi: 10.1002/ana.25279
– volume: 8
  start-page: e1028
  year: 2021
  ident: ref175
  article-title: Antiplexin D1 antibodies relate to small Fiber neuropathy and induce neuropathic pain in animals
  publication-title: Neurol Neuroimmunol Neuroinflamm.
  doi: 10.1212/NXI.0000000000001028
– volume: 59
  start-page: 404
  year: 2019
  ident: ref42
  article-title: Thymectomy may not be associated with clinical improvement in MuSK myasthenia gravis
  publication-title: Muscle Nerve
  doi: 10.1002/mus.26404
– volume: 70
  start-page: 924
  year: 2008
  ident: ref61
  article-title: SOX1 antibodies are markers of paraneoplastic Lambert-Eaton myasthenic syndrome
  publication-title: Neurology
  doi: 10.1212/01.wnl.0000281663.81079.24
– volume: 37
  start-page: 13
  year: 2022
  ident: ref171
  article-title: Therapeutic plasma exchange for peripheral neuropathy associated with trisulfated heparan disaccharide IgM antibodies: A case series of 17 patients
  publication-title: J Clin Apher
  doi: 10.1002/jca.21944
– volume: 3
  start-page: 1
  year: 2022
  ident: ref202
  article-title: Myositis-specific antibodies: overview and clinical utilization
  publication-title: Immunol Res
  doi: 10.2478/rir-2022-0001
– volume: 179
  start-page: 831
  year: 2023
  ident: ref114
  article-title: Clinical and pathophysiological implications of autoantibodies in autoimmune neuropathies
  publication-title: Rev Neurol
  doi: 10.1016/j.neurol.2023.02.064
– volume: 11
  start-page: 1756285617746640
  year: 2018
  ident: ref88
  article-title: Advances in the diagnosis, immunopathogenesis and therapies of IgM-anti-MAG antibody-mediated neuropathies
  publication-title: Ther Adv Neurol Disord
  doi: 10.1177/1756285617746640
– volume: 266
  start-page: 398
  year: 2019
  ident: ref161
  article-title: Motor neuron involvement in anti-Ma2-associated paraneoplastic neurological syndrome
  publication-title: J Neurol
  doi: 10.1007/s00415-018-9143-x
– volume: 62
  start-page: 2132
  year: 2004
  ident: ref36
  article-title: MuSK antibodies in AChR ab-seropositive MG vs AChR ab-seronegative MG
  publication-title: Neurology
  doi: 10.1212/01.WNL.0000129274.12702.92
– volume: 247
  start-page: 369
  year: 2000
  ident: ref46
  article-title: Muscle autoantibodies in subgroups of myasthenia gravis patients
  publication-title: J Neurol
  doi: 10.1007/s004150050604
– volume: 73
  start-page: 408
  year: 2013
  ident: ref197
  article-title: Cytosolic 5′-nucleotidase 1A autoimmunity in sporadic inclusion body myositis
  publication-title: Ann Neurol
  doi: 10.1002/ana.23840
– volume: 29
  start-page: 1187
  year: 2022
  ident: ref14
  article-title: The association between anti-acetylcholine receptor antibody level and clinical improvement in myasthenia gravis
  publication-title: Eur J Neurol
  doi: 10.1111/ene.15238
– volume: 367
  start-page: 577850
  year: 2022
  ident: ref27
  article-title: The clinical need for clustered AChR cell-based assay testing of seronegative MG
  publication-title: J Neuroimmunol
  doi: 10.1016/j.jneuroim.2022.577850
– volume: 337
  start-page: 212
  year: 2014
  ident: ref162
  article-title: Association of a paraneoplastic motor neuron disease with anti-Ri antibodies and a novel SOD1 I18del mutation
  publication-title: J Neurol Sci
  doi: 10.1016/j.jns.2013.11.025
– volume: 22
  start-page: 192
  year: 2021
  ident: ref170
  article-title: Clinical features and treatment response in immune-mediated small Fiber neuropathy with Trisulfated heparin disaccharide or fibroblast growth factor receptor 3 antibodies
  publication-title: J Clin Neuromuscul Dis
  doi: 10.1097/CND.0000000000000355
– volume: 6
  start-page: e23043
  year: 2017
  ident: ref1
  article-title: Structural insights into the molecular mechanisms of myasthenia gravis and their therapeutic implications
  publication-title: eLife
  doi: 10.7554/eLife.23043
– volume: 76
  start-page: 1955
  year: 2017
  ident: ref191
  article-title: 2017 European league against rheumatism/American College of Rheumatology classification criteria for adult and juvenile idiopathic inflammatory myopathies and their major subgroups
  publication-title: Ann Rheum Dis
  doi: 10.1136/annrheumdis-2017-211468
– volume: 287
  start-page: 84
  year: 2017
  ident: ref127
  article-title: Complement deposition induced by binding of anti-contactin-1 auto-antibodies is modified by immunoglobulins
  publication-title: Exp Neurol
  doi: 10.1016/j.expneurol.2016.10.006
– volume: 139
  start-page: 2617
  year: 2016
  ident: ref119
  article-title: Auto-antibodies to contactin-associated protein 1 (Caspr) in two patients with painful inflammatory neuropathy
  publication-title: Brain
  doi: 10.1093/brain/aww189
– volume: 47
  start-page: 951
  year: 1996
  ident: ref104
  article-title: The sensitivity and specificity of anti-GM1 antibody testing
  publication-title: Neurology
  doi: 10.1212/WNL.47.4.951
– volume: 58
  start-page: 452
  year: 2018
  ident: ref40
  article-title: Rituximab in refractory myasthenia gravis: extended prospective study results
  publication-title: Muscle Nerve
  doi: 10.1002/mus.26156
– volume: 100
  start-page: 1431
  year: 2007
  ident: ref87
  article-title: Myelin-associated glycoprotein (MAG): past, present and beyond
  publication-title: J Neurochem
  doi: 10.1111/j.1471-4159.2006.04319.x
– volume: 375
  start-page: 511
  year: 2016
  ident: ref17
  article-title: Randomized trial of Thymectomy in myasthenia gravis
  publication-title: N Engl J Med
  doi: 10.1056/NEJMoa1602489
– volume: 8
  start-page: 48
  year: 2011
  ident: ref103
  article-title: Multifocal motor neuropathy: diagnosis, pathogenesis and treatment strategies
  publication-title: Nat Rev Neurol
  doi: 10.1038/nrneurol.2011.175
– volume: 45
  start-page: 866
  year: 2012
  ident: ref167
  article-title: Clinical and laboratory features of neuropathies with serum IgM binding to TS-HDS
  publication-title: Muscle Nerve
  doi: 10.1002/mus.23256
– volume: 57
  start-page: 736
  year: 2001
  ident: ref73
  article-title: Anti-gal-C antibodies in GBS subsequent to mycoplasma infection: evidence of molecular mimicry
  publication-title: Neurology
  doi: 10.1212/WNL.57.4.736
– volume: 99
  start-page: S31
  year: 2022
  ident: ref58
  article-title: Testing for N-type voltage gated calcium channel antibody has limited utility in evaluating patients with suspected Lambert-Eaton Myasthenic syndrome
  publication-title: Neurology
  doi: 10.1212/01.wnl.0000903272.62514.70
– volume: 345
  start-page: 577288
  year: 2020
  ident: ref90
  article-title: Sensitivity and specificity of a commercial ELISA test for anti-MAG antibodies in patients with neuropathy
  publication-title: J Neuroimmunol
  doi: 10.1016/j.jneuroim.2020.577288
– volume: 35
  start-page: 579
  year: 2022
  ident: ref117
  article-title: Autoimmune nodopathies, an emerging diagnostic category
  publication-title: Curr Opin Neurol
  doi: 10.1097/WCO.0000000000001107
– volume: 136
  start-page: 2428
  year: 2020
  ident: ref95
  article-title: CANOMAD: a neurological monoclonal gammopathy of clinical significance that benefits from B-cell-targeted therapies
  publication-title: Blood
  doi: 10.1182/blood.2020007092
– volume: 7
  start-page: e819
  year: 2020
  ident: ref174
  article-title: Painful trigeminal neuropathy associated with anti-Plexin D1 antibody
  publication-title: Neurol Neuroimmunol Neuroinflamm.
  doi: 10.1212/NXI.0000000000000819
– volume: 37
  start-page: 36
  year: 2024
  ident: ref196
  article-title: 272nd ENMC international workshop: 10 years of progress - revision of the ENMC 2013 diagnostic criteria for inclusion body myositis and clinical trial readiness. 16-18 June 2023, Hoofddorp, The Netherlands
  publication-title: Neuromuscul Disord
  doi: 10.1016/j.nmd.2024.03.001
– volume: 44
  start-page: 36
  year: 2011
  ident: ref29
  article-title: Anti-MuSK antibody myasthenia gravis: clinical findings and response to treatment in two large cohorts
  publication-title: Muscle Nerve
  doi: 10.1002/mus.22006
– volume: 90
  start-page: e103
  year: 2018
  ident: ref108
  article-title: Autoimmune CRMP5 neuropathy phenotype and outcome defined from 105 cases
  publication-title: Neurology
  doi: 10.1212/WNL.0000000000004803
– volume: 16
  start-page: 689
  year: 2020
  ident: ref194
  article-title: Immune-mediated necrotizing myopathy: clinical features and pathogenesis
  publication-title: Nat Rev Rheumatol
  doi: 10.1038/s41584-020-00515-9
– volume: 6
  start-page: 71
  year: 1999
  ident: ref113
  article-title: Inter-laboratory validation of an ELISA for the determination of serum anti-ganglioside antibodies
  publication-title: Eur J Neurol
  doi: 10.1046/j.1468-1331.1999.610071.x
– volume: 10
  start-page: 944
  year: 2023
  ident: ref129
  article-title: Clinical profile of autoimmune nodopathy with anti-neurofascin 186 antibody
  publication-title: Ann Clin Transl Neurol
  doi: 10.1002/acn3.51775
– volume: 255
  start-page: 674
  year: 2008
  ident: ref82
  article-title: Bickerstaff’s brainstem encephalitis and fisher syndrome form a continuous spectrum: clinical analysis of 581 cases
  publication-title: J Neurol
  doi: 10.1007/s00415-008-0775-0
– volume: 8
  start-page: e1032
  year: 2021
  ident: ref147
  article-title: Argonaute autoantibodies as biomarkers in autoimmune neurologic diseases
  publication-title: Neurol Neuroimmunol Neuroinflamm
  doi: 10.1212/NXI.0000000000001032
– volume: 22
  start-page: 395
  year: 2023
  ident: ref21
  article-title: Safety and efficacy of zilucoplan in patients with generalised myasthenia gravis (RAISE): a randomised, double-blind, placebo-controlled, phase 3 study
  publication-title: Lancet Neurol
  doi: 10.1016/S1474-4422(23)00080-7
– volume: 10
  start-page: e200105
  year: 2023
  ident: ref148
  article-title: Anti-AGO1 antibodies identify a subset of autoimmune sensory Neuronopathy
  publication-title: Neurol Neuroimmunol Neuroinflamm.
  doi: 10.1212/NXI.0000000000200105
– volume: 1412
  start-page: 82
  year: 2018
  ident: ref31
  article-title: Myasthenia gravis with antibodies to MuSK: an update
  publication-title: Ann N Y Acad Sci
  doi: 10.1111/nyas.13518
– volume: 6
  start-page: e603
  year: 2019
  ident: ref131
  article-title: Anti-pan-neurofascin IgG3 as a marker of fulminant autoimmune neuropathy
  publication-title: Neurol Neuroimmunol Neuroinflamm.
  doi: 10.1212/NXI.0000000000000603
– volume: 449
  start-page: 43
  year: 2015
  ident: ref4
  article-title: An update on laboratory diagnosis in myasthenia gravis
  publication-title: Clin Chim Acta
  doi: 10.1016/j.cca.2015.07.030
– volume: 31
  start-page: 652
  year: 2005
  ident: ref184
  article-title: Rippling muscle disease may be caused by "silent" action potentials in the tubular system of skeletal muscle fibers
  publication-title: Muscle Nerve
  doi: 10.1002/mus.20307
– volume: 15
  start-page: 295
  year: 2010
  ident: ref116
  article-title: European Federation of Neurological Societies/peripheral nerve society guideline on management of multifocal motor neuropathy. Report of a joint task force of the European Federation of Neurological Societies and the peripheral nerve society – first revision
  publication-title: J Peripher Nerv Syst
  doi: 10.1111/j.1529-8027.2010.00290.x
– volume: 1413
  start-page: 143
  year: 2018
  ident: ref28
  article-title: Serological and experimental studies in different forms of myasthenia gravis
  publication-title: Ann N Y Acad Sci
  doi: 10.1111/nyas.13592
– start-page: awae302
  year: 2024
  ident: ref183
  article-title: A role for leucine-rich, glioma inactivated 1 in regulating pain sensitivity
  publication-title: Brain
  doi: 10.1093/brain/awae302
– volume: 103
  start-page: e209725
  year: 2024
  ident: ref205
  article-title: Antibodies in autoimmune neuropathies: what to test, how to test, why to test
  publication-title: Neurology
  doi: 10.1212/WNL.0000000000209725
– volume: 40
  start-page: 635
  year: 1996
  ident: ref77
  article-title: Acute motor axonal neuropathy: An antibody-mediated attack on axolemma
  publication-title: Ann Neurol
  doi: 10.1002/ana.410400414
– start-page: S23
  year: 2023
  ident: ref130
  article-title: Autoimmune nodo-paranodopathies 10 years later: clinical features, pathophysiology and treatment
  publication-title: J Peripher Nerv Syst
  doi: 10.1111/jns.12569
– volume: 18
  start-page: e0284409
  year: 2023
  ident: ref200
  article-title: Clinical significance of anti-NT5c1A autoantibody in Korean patients with inflammatory myopathies
  publication-title: PLoS One
  doi: 10.1371/journal.pone.0284409
– volume: 49
  start-page: 2370
  year: 2010
  ident: ref203
  article-title: Diagnostic performance and validation of autoantibody testing in myositis by a commercial line blot assay
  publication-title: Rheumatology
  doi: 10.1093/rheumatology/keq281
– volume: 49
  start-page: 483
  year: 2014
  ident: ref13
  article-title: Does change in acetylcholine receptor antibody level correlate with clinical change in myasthenia gravis?
  publication-title: Muscle Nerve
  doi: 10.1002/mus.23944
– volume: 58
  start-page: 885
  year: 2001
  ident: ref47
  article-title: Anti-titin antibodies in myasthenia gravis
  publication-title: Arch Neurol
  doi: 10.1001/archneur.58.6.885
– volume: 13
  start-page: 575
  year: 2014
  ident: ref157
  article-title: A novel non-rapid-eye movement and rapid-eye-movement parasomnia with sleep breathing disorder associated with antibodies to IgLON5: a case series, characterisation of the antigen, and post-mortem study
  publication-title: Lancet Neurol
  doi: 10.1016/S1474-4422(14)70051-1
– volume: 10
  start-page: e200081
  year: 2023
  ident: ref132
  article-title: Anti-LGI4 antibody is a novel Juxtaparanodal autoantibody for chronic inflammatory demyelinating polyneuropathy
  publication-title: Neurol Neuroimmunol Neuroinflamm
  doi: 10.1212/NXI.0000000000200081
– volume: 134
  start-page: 1343
  year: 2005
  ident: ref146
  article-title: Regulation of neuronal death and calcitonin gene-related peptide by fibroblast growth factor-2 and FGFR3 after peripheral nerve injury: evidence from mouse mutants
  publication-title: Neuroscience
  doi: 10.1016/j.neuroscience.2005.04.066
– volume: 56
  start-page: 1227
  year: 2001
  ident: ref74
  article-title: Guillain–Barré syndrome associated with IgG monospecific to ganglioside GD1b
  publication-title: Neurology
  doi: 10.1212/WNL.56.9.1227
– volume: 4
  start-page: e357
  year: 2017
  ident: ref34
  article-title: IgG-specific cell-based assay detects potentially pathogenic MuSK-abs in seronegative MG
  publication-title: Neurol Neuroimmunol Neuroinflamm.
  doi: 10.1212/NXI.0000000000000357
– volume: 146
  start-page: 13
  year: 2009
  ident: ref138
  article-title: Other autonomic neuropathies associated with ganglionic antibody
  publication-title: Auton Neurosci
  doi: 10.1016/j.autneu.2008.10.022
– volume: 1412
  start-page: 113
  year: 2018
  ident: ref2
  article-title: Myasthenia gravis: the role of complement at the neuromuscular junction
  publication-title: Ann N Y Acad Sci
  doi: 10.1111/nyas.13522
– volume: 2011
  start-page: 1
  year: 2011
  ident: ref15
  article-title: Thymoma in myasthenia gravis: from diagnosis to treatment
  publication-title: Autoimmune Dis
  doi: 10.4061/2011/474512
– volume: 95
  start-page: 605
  year: 1998
  ident: ref66
  article-title: Mapping immunoreactive epitopes in the human peripheral nervous system using human monoclonal anti-GM1 ganglioside antibodies
  publication-title: Acta Neuropathol
  doi: 10.1007/s004010050847
– volume: 31
  start-page: 220
  year: 1981
  ident: ref11
  article-title: No direct correlation between serum antiacetylcholine receptor antibody levels and clinical state of individual patients with myasthenia gravis
  publication-title: Neurology
  doi: 10.1212/WNL.31.2.220
– volume: 34
  start-page: 714
  year: 2021
  ident: ref177
  article-title: Neuromuscular hyperexcitability syndromes
  publication-title: Curr Opin Neurol
  doi: 10.1097/WCO.0000000000000963
– volume: 280
  start-page: 8
  year: 2016
  ident: ref192
  article-title: Myositis-specific autoantibodies: an important tool to support diagnosis of myositis
  publication-title: J Intern Med
  doi: 10.1111/joim.12451
– volume: 24
  start-page: 73
  year: 1988
  ident: ref101
  article-title: A treatable multifocal motor neuropathy with antibodies to GM1 ganglioside
  publication-title: Ann Neurol
  doi: 10.1002/ana.410240113
– volume: 27
  start-page: 188
  year: 2003
  ident: ref166
  article-title: Sensory neuropathy with monoclonal IgM binding to a trisulfated heparin disaccharide
  publication-title: Muscle Nerve
  doi: 10.1002/mus.10301
– volume: 33
  start-page: 1019
  year: 2014
  ident: ref78
  article-title: Seroprevalence of campylobacteriosis and relevant post-infectious sequelae
  publication-title: Eur J Clin Microbiol Infect Dis
  doi: 10.1007/s10096-013-2040-4
– volume: 122
  start-page: 449
  year: 1999
  ident: ref79
  article-title: The distribution of ganglioside-like moieties in peripheral nerves
  publication-title: Brain
  doi: 10.1093/brain/122.3.449
– volume: 57
  start-page: 1596
  year: 2000
  ident: ref49
  article-title: The severity of myasthenia gravis correlates with the serum concentration of titin and ryanodine receptor antibodies
  publication-title: Arch Neurol
  doi: 10.1001/archneur.57.11.1596
– volume: 75
  start-page: 1528
  year: 2018
  ident: ref190
  article-title: Development of a new classification system for idiopathic inflammatory myopathies based on clinical manifestations and myositis-specific autoantibodies
  publication-title: JAMA Neurol
  doi: 10.1001/jamaneurol.2018.2598
– volume: 31
  start-page: 677
  year: 1992
  ident: ref80
  article-title: Serum IgG antibody to ganglioside GQ1b is a possible marker of Miller fisher syndrome
  publication-title: Ann Neurol
  doi: 10.1002/ana.410310619
– volume: 96
  start-page: 114
  year: 2021
  ident: ref18
  article-title: International consensus guidance for Management of Myasthenia Gravis: 2020 update
  publication-title: Neurology
  doi: 10.1212/WNL.0000000000011124
– volume: 58
  start-page: 371
  year: 1983
  ident: ref8
  article-title: Anti-acetylcholine receptor antibodies in myasthenia gravis. Part 2.Clinical and serological follow-up of individual patients
  publication-title: J Neurol Sci
  doi: 10.1016/0022-510X(83)90096-5
– volume: 135
  start-page: 1081
  year: 2012
  ident: ref30
  article-title: Muscle-specific kinase myasthenia gravis IgG4 autoantibodies cause severe neuromuscular junction dysfunction in mice
  publication-title: Brain
  doi: 10.1093/brain/aws025
– volume: 343
  start-page: 847
  year: 2000
  ident: ref133
  article-title: Autoantibodies to ganglionic acetylcholine receptors in autoimmune autonomic neuropathies
  publication-title: N Engl J Med
  doi: 10.1056/NEJM200009213431204
– volume: 16
  start-page: 934
  year: 2017
  ident: ref164
  article-title: The diagnostic challenge of small fibre neuropathy: clinical presentations, evaluations, and causes
  publication-title: Neurology
  doi: 10.1016/S1474-4422(17)30329-0
– volume: 68
  start-page: 66
  year: 2016
  ident: ref198
  article-title: Cytosolic 5′-nucleotidase 1A as a target of circulating autoantibodies in autoimmune diseases
  publication-title: Arthritis Care Res
  doi: 10.1002/acr.22600
– volume: 20
  start-page: 526
  year: 2021
  ident: ref22
  article-title: Safety, efficacy, and tolerability of efgartigimod in patients with generalised myasthenia gravis (ADAPT): a multicentre, randomised, placebo-controlled, phase 3 trial
  publication-title: Lancet Neurol
  doi: 10.1016/S1474-4422(21)00159-9
– volume: 9
  start-page: e114060
  year: 2014
  ident: ref10
  article-title: Repeated acetyl-choline receptor antibody- concentrations and association to clinical myasthenia gravis development
  publication-title: PLoS One
  doi: 10.1371/journal.pone.0114060
– volume: 21
  start-page: 176
  year: 2022
  ident: ref48
  article-title: Epidemiology, diagnostics, and biomarkers of autoimmune neuromuscular junction disorders
  publication-title: Lancet Neurol
  doi: 10.1016/S1474-4422(21)00297-0
– volume: 7
  start-page: e771
  year: 2020
  ident: ref125
  article-title: Contactin-1 autoimmunity: serologic, neurologic, and pathologic correlates
  publication-title: Neurol Neuroimmunol Neuroinflamm
  doi: 10.1212/NXI.0000000000000771
– volume: 67
  start-page: 330
  year: 2010
  ident: ref151
  article-title: Paraneoplastic neurologic syndrome in the PNS Euronetwork database: a European study from 20 centers
  publication-title: Arch Neurol
  doi: 10.1001/archneurol.2009.341
– volume: 44
  start-page: 976
  year: 1998
  ident: ref155
  article-title: Utility of anti-Hu antibodies in the diagnosis of paraneoplastic sensory neuropathy
  publication-title: Ann Neurol
  doi: 10.1002/ana.410440620
– volume: 11
  start-page: 73
  year: 1948
  ident: ref150
  article-title: Primary sensory neuropathy with muscular changes associated with carcinoma
  publication-title: J Neurol Neurosurg Psychiatry
  doi: 10.1136/jnnp.11.2.73
– volume: 33
  start-page: 1276
  year: 1983
  ident: ref7
  article-title: Acetylcholine re-ceptor antibody and clinical response to thymectomy in myasthenia gravis
  publication-title: Neurology
  doi: 10.1212/WNL.33.10.1276
– volume: 38
  start-page: 100846
  year: 2023
  ident: ref6
  article-title: SCREAM study investigators. A multicentre, prospective, double-blind study comparing the accuracy of autoantibody diagnostic assays in myasthenia gravis: the SCREAM study
  publication-title: Lancet Reg Health West Pac
  doi: 10.1016/j.lanwpc.2023.100846
– volume: 60
  start-page: 14
  year: 2019
  ident: ref19
  article-title: Long-term safety and efficacy of eculizumab in generalized myasthenia gravis
  publication-title: Muscle Nerve
  doi: 10.1002/mus.26447
– volume: 10
  start-page: 769
  year: 2019
  ident: ref64
  article-title: Caveats and pitfalls of SOX1 autoantibody testing with a commercial line blot assay in paraneoplastic neurological investigations
  publication-title: Front Immunol
  doi: 10.3389/fimmu.2019.00769
– volume: 79
  start-page: 808
  year: 2022
  ident: ref186
  article-title: Identification of Caveolae-associated protein 4 autoantibodies as a biomarker of immune-mediated rippling muscle disease in adults
  publication-title: JAMA Neurol
  doi: 10.1001/jamaneurol.2022.1357
– volume: 45
  start-page: 168
  year: 1999
  ident: ref67
  article-title: Anti-GD1a antibody is associated with axonal but not demyelinating forms of Guillain-Barre syndrome
  publication-title: Ann Neurol
  doi: 10.1002/1531-8249(199902)45:2<168:AID-ANA6>3.0.CO;2-6
– volume: 17
  start-page: 62
  year: 2012
  ident: ref75
  article-title: Nodal proteins are target antigens in Guillain-Barré syndrome
  publication-title: J Peripher Nerv Syst
  doi: 10.1111/j.1529-8027.2012.00372.x
– volume: 97
  start-page: 4198
  year: 2000
  ident: ref59
  article-title: Serological identification of embryonic neural proteins as highly immunogenic tumor antigens in small cell lung cancer
  publication-title: Proc Natl Acad Sci USA
  doi: 10.1073/pnas.97.8.4198
– volume: 26
  start-page: 992
  year: 2019
  ident: ref181
  article-title: Acquired neuromyotonia in thymoma-associated myasthenia gravis: a clinical and serological study
  publication-title: Eur J Neurol
  doi: 10.1111/ene.13922
– volume: 196
  start-page: 113
  year: 1982
  ident: ref12
  article-title: A prospective study of thymectomy and serum acetylcholine receptor antibodies in myasthenia gravis
  publication-title: Ann Surg
  doi: 10.1097/00000658-198208000-00001
– volume: 40
  start-page: 1111
  year: 2019
  ident: ref50
  article-title: Italian recommendations for the diagnosis and treatment of myasthenia gravis
  publication-title: Neurol Sci
  doi: 10.1007/s10072-019-03746-1
– volume: 70
  start-page: 50
  year: 2001
  ident: ref81
  article-title: Anti-GQ1b IgG antibody syndrome: clinical and immunological range
  publication-title: J Neurol Neurosurg Psychiatry
  doi: 10.1136/jnnp.70.1.50
– volume: 97
  start-page: 806
  year: 2018
  ident: ref180
  article-title: Immune or genetic-mediated disruption of CASPR2 causes pain hypersensitivity due to enhanced primary afferent excitability
  publication-title: Neuron
  doi: 10.1016/j.neuron.2018.01.033
– volume: 270
  start-page: 3862
  year: 2023
  ident: ref20
  article-title: Long-term efficacy and safety of ravulizumab in adults with anti-acetylcholine receptor antibody-positive generalized myasthenia gravis: results from the phase 3 CHAMPION MG open-label extension
  publication-title: J Neurol
  doi: 10.1007/s00415-023-11699-x
– volume: 67
  start-page: 505
  year: 2006
  ident: ref35
  article-title: Anti-MuSK antibodies: correlation with myasthenia gravis severity
  publication-title: Neurology
  doi: 10.1212/01.wnl.0000228225.23349.5d
– volume: 21
  start-page: 52
  year: 2019
  ident: ref69
  article-title: Anti-GQ1b Spectrum disorders
  publication-title: J Clin Neuromuscul Dis
  doi: 10.1097/CND.0000000000000241
– volume: 3
  start-page: 552
  year: 2016
  ident: ref41
  article-title: Rituximab in refractory myasthenia gravis: a prospective, open-label study with long-term follow-up
  publication-title: Ann Clin Transl Neurol
  doi: 10.1002/acn3.314
– volume: 49
  start-page: 629
  year: 2014
  ident: ref96
  article-title: Acute and chronic ataxic neuropathies with disialosyl antibodies: a continuous clinical spectrum and a common pathophysiological mechanism
  publication-title: Muscle Nerve
  doi: 10.1002/mus.24192
– volume: 140
  start-page: 1851
  year: 2017
  ident: ref121
  article-title: Autoantibodies to nodal isoforms of neurofascin in chronic inflammatory demyelinating polyneuropathy
  publication-title: Brain
  doi: 10.1093/brain/awx124
– volume: 2012
  start-page: 1
  year: 2012
  ident: ref65
  article-title: Ganglioside biochemistry
  publication-title: Int Scholarly Res Notices
  doi: 10.5402/2012/506160
– volume: 144
  start-page: 1183
  year: 2021
  ident: ref128
  article-title: Antibodies to the Caspr1/contactin-1 complex in chronic inflammatory demyelinating polyradiculoneuropathy
  publication-title: Brain
  doi: 10.1093/brain/awab014
– volume: 20
  start-page: 21
  year: 2018
  ident: ref193
  article-title: Immune-mediated necrotizing myopathy
  publication-title: Curr Rheumatol Rep
  doi: 10.1007/s11926-018-0732-6
– volume: 28
  start-page: 3556
  year: 2021
  ident: ref94
  article-title: European academy of neurology/peripheral nerve society guideline on diagnosis and treatment of chronic inflammatory demyelinating polyradiculoneuropathy: report of a joint task force-second revision
  publication-title: Eur J Neurol
  doi: 10.1111/ene.14959
– volume: 82
  start-page: 879
  year: 2014
  ident: ref120
  article-title: Neurofascin IgG4 antibodies in CIDP associate with disabling tremor and poor response to IVIg
  publication-title: Neurology
  doi: 10.1212/WNL.0000000000000205
– volume: 66
  start-page: 575
  year: 2014
  ident: ref195
  article-title: Autoantibodies to RuvBL1 and RuvBL2: a novel systemic sclerosis-related antibody associated with diffuse cutaneous and skeletal muscle involvement
  publication-title: Arthritis Care Res
  doi: 10.1002/acr.22163
– volume: 54
  start-page: 220
  year: 2016
  ident: ref57
  article-title: P/Q- and N-type calcium-channel antibodies: oncological, neurological, and serological accompaniments
  publication-title: Muscle Nerve
  doi: 10.1002/mus.25027
– volume: 132
  start-page: 1723
  year: 2009
  ident: ref141
  article-title: The pattern and diagnostic criteria of sensory neuronopathy: a case-control study
  publication-title: Brain
  doi: 10.1093/brain/awp136
– volume: 63
  start-page: 1947
  year: 2004
  ident: ref156
  article-title: Value of Hu antibody determinations in the follow-up of paraneoplastic neurologic syndromes
  publication-title: Neurology
  doi: 10.1212/01.WNL.0000144340.03364.BF
– volume: 32
  start-page: 594
  year: 2022
  ident: ref204
  article-title: 256th ENMC international workshop: myositis specific and associated autoantibodies (MSA-ab): Amsterdam, The Netherlands, 8-10 October 2021
  publication-title: Neuromuscul Disord
  doi: 10.1016/j.nmd.2022.05.011
– volume: 8
  start-page: e1014
  year: 2021
  ident: ref112
  article-title: Updated diagnostic criteria for paraneoplastic neurologic syndromes
  publication-title: Neurol Neuroimmunol Neuroinflamm
  doi: 10.1212/NXI.0000000000001014
– volume: 35
  start-page: 597
  year: 2022
  ident: ref178
  article-title: Autoimmune neuromyotonia
  publication-title: Curr Opin Neurol
  doi: 10.1097/WCO.0000000000001104
– volume: 72
  start-page: 767
  year: 2002
  ident: ref68
  article-title: Anti-GT1a IgG in Guillain-Barre syndrome
  publication-title: J Neurol Neurosurg Psychiatry
  doi: 10.1136/jnnp.72.6.767
– volume: 92
  start-page: 1089
  year: 2021
  ident: ref86
  article-title: IgG1pan-neurofascin antibodies identify a severe yet treatable neuropathy with a high mortality
  publication-title: J Neurol Neurosurg Psychiatry
  doi: 10.1136/jnnp-2021-326343
– volume: 52
  start-page: 386
  year: 2015
  ident: ref135
  article-title: Clinical experience of seropositive ganglionic acetylcholine receptor antibody in a tertiary neurology referral center
  publication-title: Muscle Nerve
  doi: 10.1002/mus.24559
– volume: 10
  start-page: 745
  year: 2019
  ident: ref199
  article-title: Anti-NT5c1A autoantibodies as biomarkers in inclusion body myositis
  publication-title: Front Immunol
  doi: 10.3389/fimmu.2019.00745
– volume: 91
  start-page: 140
  year: 2020
  ident: ref102
  article-title: Multifocal motor neuropathy: controversies and priorities
  publication-title: J Neurol Neurosurg Psychiatry
  doi: 10.1136/jnnp-2019-321532
– volume: 29
  start-page: 3547
  year: 2022
  ident: ref99
  article-title: Anti-disialosyl-immunoglobulin M chronic autoimmune neuropathies: a nationwide multicenter retrospective study
  publication-title: Eur J Neurol
  doi: 10.1111/ene.15523
– volume: 1275
  start-page: 70
  year: 2012
  ident: ref62
  article-title: SOX1 antibodies in Lambert-Eaton myasthenic syndrome and screening for small cell lung carcinoma
  publication-title: Ann N Y Acad Sci
  doi: 10.1111/j.1749-6632.2012.06772.x
– volume: 91
  start-page: 66
  year: 2022
  ident: ref176
  article-title: Novel autoantibodies in idiopathic small Fiber neuropathy
  publication-title: Ann Neurol
  doi: 10.1002/ana.26268
– volume: 7
  start-page: 86
  year: 2021
  ident: ref189
  article-title: Idiopathic inflammatory myopathies
  publication-title: Nat Rev Dis Primers
  doi: 10.1038/s41572-021-00321-x
– volume: 270
  start-page: 1478
  year: 2023
  ident: ref33
  article-title: Clinical pitfalls and serological diagnostics of MuSK myasthenia gravis
  publication-title: J Neurol
  doi: 10.1007/s00415-022-11458-4
SSID ssj0000399363
Score 2.36185
SecondaryResourceType review_article
Snippet A great proportion of neuromuscular diseases are immune-mediated, included myasthenia gravis, Lambert-Eaton myasthenic syndrome, acute- and chronic-onset...
SourceID doaj
proquest
pubmed
crossref
SourceType Open Website
Aggregation Database
Index Database
Enrichment Source
StartPage 1495205
SubjectTerms autoantibodies
clinical practice
detection method
neuromuscular diseases
review
Title Autoantibodies in neuromuscular disorders: a review of their utility in clinical practice
URI https://www.ncbi.nlm.nih.gov/pubmed/39555481
https://www.proquest.com/docview/3129688161
https://doaj.org/article/c7ced2568e8e4ae280ff84d218eceaa4
Volume 15
WOSCitedRecordID wos001356556900001&url=https%3A%2F%2Fcvtisr.summon.serialssolutions.com%2F%23%21%2Fsearch%3Fho%3Df%26include.ft.matches%3Dt%26l%3Dnull%26q%3D
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
journalDatabaseRights – providerCode: PRVAON
  databaseName: DOAJ Directory of Open Access Journals
  customDbUrl:
  eissn: 1664-2295
  dateEnd: 99991231
  omitProxy: false
  ssIdentifier: ssj0000399363
  issn: 1664-2295
  databaseCode: DOA
  dateStart: 20100101
  isFulltext: true
  titleUrlDefault: https://www.doaj.org/
  providerName: Directory of Open Access Journals
– providerCode: PRVHPJ
  databaseName: ROAD: Directory of Open Access Scholarly Resources
  customDbUrl:
  eissn: 1664-2295
  dateEnd: 99991231
  omitProxy: false
  ssIdentifier: ssj0000399363
  issn: 1664-2295
  databaseCode: M~E
  dateStart: 20100101
  isFulltext: true
  titleUrlDefault: https://road.issn.org
  providerName: ISSN International Centre
link http://cvtisr.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwrV1Nb9QwEB2VqkJcEKVAl4_Klbih0GycxBNubdWqB1r1QNFyshxnLK0ESdXd5chvZ8bOrvYCXLj4ENmJM57kvZE9bwDei6K6o4Iyrb3OSsx91nRRG4-5bR2cKaLO9tfP5uYGZ7PmdqvUl5wJS_LAyXAn3njqGJeRkOSumIeAZcfIRJ6ci0qgzHq2gqn4DxbcrXXKkuEorDkJog_J8WBRfpSgoJB6dVtIFAX7_8wyI9pcPoOnI01Up2l6-7BD_XN4fD1uhB_At9PVcmCjzNtBjgGqea-iMuWPVTpYqrpRVXPxSTmV8lPUEFTcF1DsbMK-ZdQ6M1Kt06VewN3lxZfzq2yskpB5BqBl1lHIS48Vthjq0FTGkMlbx8gTGJ9Mh9xS3laiLehKmpahbX3jmGjozmsk_RJ2-6GnQ1DOUFmYaWWYp5SUe8d8jmrfotFt3qCbwHRtMetHCXGpZPHdcighVrbRylasbEcrT-DDZsx9EtD4a-8zWYhNTxG_jhfYJezoEvZfLjGB4_UyWv5YZAfE9TSsFlYzu6kRmeVO4FVa382jdFMxtcLp6_8xhTfwRF4rJS2-hd3lw4rewZ7_uZwvHo7gkZnhUfRYbq9_XfwGP3bxKg
linkProvider Directory of Open Access Journals
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Autoantibodies+in+neuromuscular+disorders%3A+a+review+of+their+utility+in+clinical+practice&rft.jtitle=Frontiers+in+neurology&rft.au=Loser%2C+Valentin&rft.au=Vicino%2C+Alex&rft.au=Th%C3%A9audin%2C+Marie&rft.date=2024-11-01&rft.issn=1664-2295&rft.eissn=1664-2295&rft.volume=15&rft.spage=1495205&rft_id=info:doi/10.3389%2Ffneur.2024.1495205&rft.externalDBID=NO_FULL_TEXT
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1664-2295&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1664-2295&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1664-2295&client=summon